| 000 | 01735 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517092940.0 | ||
| 264 | 0 | _c20170717 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1096-8652 | ||
| 024 | 7 |
_a10.1002/ajh.24403 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aParry, Helen Marie | |
| 245 | 0 | 0 |
_aCytomegalovirus infection does not impact on survival or time to first treatment in patients with chronic lymphocytic leukemia. _h[electronic resource] |
| 260 |
_bAmerican journal of hematology _c08 2016 |
||
| 300 |
_a776-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTime-to-Treatment |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aDamery, Sarah | |
| 700 | 1 | _aHudson, Christopher | |
| 700 | 1 | _aMaurer, Matthew J | |
| 700 | 1 | _aCerhan, James R | |
| 700 | 1 | _aPachnio, Annette | |
| 700 | 1 | _aBegum, Jusnara | |
| 700 | 1 | _aSlager, Susan L | |
| 700 | 1 | _aFegan, Christopher | |
| 700 | 1 | _aMan, Stephen | |
| 700 | 1 | _aPepper, Christopher | |
| 700 | 1 | _aShanafelt, Tait D | |
| 700 | 1 | _aPratt, Guy | |
| 700 | 1 | _aMoss, Paul A H | |
| 773 | 0 |
_tAmerican journal of hematology _gvol. 91 _gno. 8 _gp. 776-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.24403 _zAvailable from publisher's website |
| 999 |
_c25968479 _d25968479 |
||